HomeCompareTEKY vs KMB

TEKY vs KMB: Dividend Comparison 2026

TEKY yields 0.28% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $25.8K in total portfolio value
10 years
TEKY
TEKY
● Live price
0.28%
Share price
$33.73
Annual div
$0.09
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.1K
Annual income
$28.33
Full TEKY calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — TEKY vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTEKYKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TEKY + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TEKY pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TEKY
Annual income on $10K today (after 15% tax)
$23.65/yr
After 10yr DRIP, annual income (after tax)
$24.08/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, KMB beats the other by $4,405.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TEKY + KMB for your $10,000?

TEKY: 50%KMB: 50%
100% KMB50/50100% TEKY
Portfolio after 10yr
$33.0K
Annual income
$2,619.83/yr
Blended yield
7.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

TEKY
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TEKY buys
0
KMB buys
0
No recent congressional trades found for TEKY or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTEKYKMB
Forward yield0.28%5.25%
Annual dividend / share$0.09$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$20.1K$45.9K
Annual income after 10y$28.33$5,211.33
Total dividends collected$281.00$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TEKY vs KMB ($10,000, DRIP)

YearTEKY PortfolioTEKY Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$10,728$27.83$11,314$613.68$586.00KMB
2$11,507$27.90$12,865$759.19$1.4KKMB
3$12,340$27.97$14,709$943.96$2.4KKMB
4$13,232$28.03$16,919$1,180.17$3.7KKMB
5$14,186$28.09$19,588$1,484.33$5.4KKMB
6$15,207$28.14$22,838$1,879.06$7.6KKMB
7$16,300$28.20$26,832$2,395.60$10.5KKMB
8$17,469$28.25$31,788$3,077.63$14.3KKMB
9$18,721$28.29$38,000$3,986.82$19.3KKMB
10$20,059$28.33$45,872$5,211.33$25.8KKMB

TEKY vs KMB: Complete Analysis 2026

TEKYStock

TEKY invests globally in companies at the forefront in developing or enabling next-generation technologies, particularly artificial intelligence (AI). The fund targets approximately 40 to 60 companies across three segments: hardware infrastructure, enabling technologies, and AI application vendors. A proprietary data science platform is used to screen and rank potential securities based on their business exposure to AI, considering factors like product offerings, intellectual property, R&D efforts, revenue, and market presence. From this universe, a bottom-up stock selection process is employed, using tailored valuations approaches, revenue-based for early-stage firms and EV/EBITDA for established businesses. Investments include common and preferred stocks, ADRs, GDRs, warrants, rights, and participatory notes. Additionally, it may use futures and swaps for hedging or enhancing returns. The fund may hedge foreign currency exposure through forward contracts, depending on market conditions.

Full TEKY Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this TEKY vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TEKY vs SCHDTEKY vs JEPITEKY vs OTEKY vs KOTEKY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.